Latest News and Press Releases
Want to stay updated on the latest news?
-
The neuroprotective agents market in North America is growing at approximately 4.5% CAGR through 2030, with AI-driven approaches.
-
The global market for neuroprotective agents was valued at $41.2 billion in 2024 and is expected to reach $60.9 billion by the end of 2030.
-
Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Neurology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by...
-
Boston, Oct. 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Anti-Parkinson's Drugs: Global Markets to 2030” is projected to grow from $6.1 billion in 2025 to $9.2...
-
Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Leigh Syndrome Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's...
-
Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Aneurysmal Subarachnoid Hemorrhage Market - A Global and Regional Analysis: Focus on Drug Class and Country Analysis - Analysis and Forecast,...
-
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
-
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Neurologic Disorders Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
-
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market (2024 Edition): Size, Trends, Opportunities and Forecast by Treatment Type, Drug, Distribution Channel, and...
-
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...